Your work spans three spaces—doing deep design, leading design teams, and amplifying design thinking. But they all collide on the same problem: the system around you is becoming more turbulent, not less capable. You’re being asked to hold outcomes steady while the organisation becomes more political, more interdependent, more contradictory. Priorities that contradict each other … Read more
Why This Framework Works the Way It Does Most business books assume you’ll read Chapter 1, then Chapter 2, holding concepts in memory as you build toward mastery. They assume sustained attention. Linear progression. Quiet focus. That’s not how transformation leaders actually work. You’re grabbing ten minutes between crisis meetings. Scanning for something applicable to … Read more
What 15 years of ground-level observation reveals about DSO’s real trajectory BOTTOM LINE Published metrics tell one story. Ground-level observation tells another. I’ve watched Bayer’s evolution for over 15 years—close enough to see patterns that analyst reports miss. The signals that predict transformation success or failure aren’t in quarterly earnings. They’re in who stays, who … Read more
Thriving in Turbulence is live on Amazon. Here’s the diagnostic system behind it. Monday morning. Your transformation is three months in. Everyone’s working harder than ever. Standups happen. Retrospectives are religious. You’ve got OKRs, Kanban boards, and detailed roadmaps. Yet delivery is slowing. Dependencies multiply. Your best people look exhausted. Stakeholders escalate to your boss. … Read more
Precedents, patterns, and why scale changes everything BOTTOM LINE The largest Western self-management experiment before Bayer was Zappos. They had 8 years as “best place to work,” 1,500 employees, and voluntary departures. They still quietly retreated from holacracy. Bayer has 60× the scale, a trust deficit, and involuntary layoffs. The precedent doesn’t predict failure—but it … Read more
Why DSO might be the right destination reached by the wrong path BOTTOM LINE Bayer’s Dynamic Shared Ownership isn’t wrong. The diagnostic sequence is. Harvard Business School is already writing the case study. The question they’re examining: “Could fewer bosses truly drive innovation, or was this an unsustainable gamble?” CIRCA-CLEAR suggests a different question: Is … Read more